nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—Pazopanib—kidney cancer	0.617	1	CrCtD
Rilpivirine—ABCB1—kidney cancer	0.0607	1	CbGaD
Rilpivirine—NR1I2—Erlotinib—kidney cancer	0.0434	0.175	CbGbCtD
Rilpivirine—NR1I2—Paclitaxel—kidney cancer	0.0398	0.16	CbGbCtD
Rilpivirine—SLCO1B3—Paclitaxel—kidney cancer	0.0156	0.0629	CbGbCtD
Rilpivirine—SLCO1B1—Pazopanib—kidney cancer	0.0139	0.0561	CbGbCtD
Rilpivirine—ABCG2—Pazopanib—kidney cancer	0.011	0.0446	CbGbCtD
Rilpivirine—ABCG2—Dactinomycin—kidney cancer	0.0101	0.0408	CbGbCtD
Rilpivirine—ABCG2—Erlotinib—kidney cancer	0.00788	0.0318	CbGbCtD
Rilpivirine—ABCB1—Temsirolimus—kidney cancer	0.00758	0.0306	CbGbCtD
Rilpivirine—ABCG2—Paclitaxel—kidney cancer	0.00722	0.0291	CbGbCtD
Rilpivirine—CYP3A4—Everolimus—kidney cancer	0.00673	0.0271	CbGbCtD
Rilpivirine—ABCG2—Sorafenib—kidney cancer	0.00641	0.0259	CbGbCtD
Rilpivirine—ABCG2—Vincristine—kidney cancer	0.00622	0.0251	CbGbCtD
Rilpivirine—ABCG2—Sunitinib—kidney cancer	0.00519	0.021	CbGbCtD
Rilpivirine—CYP1A2—Pazopanib—kidney cancer	0.00456	0.0184	CbGbCtD
Rilpivirine—CYP3A4—Temsirolimus—kidney cancer	0.00454	0.0183	CbGbCtD
Rilpivirine—CYP2B6—Sorafenib—kidney cancer	0.00451	0.0182	CbGbCtD
Rilpivirine—ABCB1—Pazopanib—kidney cancer	0.00398	0.0161	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—kidney cancer	0.00389	0.0157	CbGbCtD
Rilpivirine—ABCB1—Dactinomycin—kidney cancer	0.00364	0.0147	CbGbCtD
Rilpivirine—CYP1A2—Erlotinib—kidney cancer	0.00325	0.0131	CbGbCtD
Rilpivirine—ABCB1—Gemcitabine—kidney cancer	0.00288	0.0116	CbGbCtD
Rilpivirine—CYP2C19—Sorafenib—kidney cancer	0.00286	0.0116	CbGbCtD
Rilpivirine—ABCB1—Erlotinib—kidney cancer	0.00284	0.0115	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—kidney cancer	0.00274	0.011	CbGbCtD
Rilpivirine—CYP1A2—Sorafenib—kidney cancer	0.00264	0.0107	CbGbCtD
Rilpivirine—ABCB1—Paclitaxel—kidney cancer	0.0026	0.0105	CbGbCtD
Rilpivirine—CYP3A4—Pazopanib—kidney cancer	0.00239	0.00963	CbGbCtD
Rilpivirine—ABCB1—Sorafenib—kidney cancer	0.00231	0.00932	CbGbCtD
Rilpivirine—ABCB1—Vinblastine—kidney cancer	0.00228	0.00921	CbGbCtD
Rilpivirine—ABCB1—Vincristine—kidney cancer	0.00224	0.00905	CbGbCtD
Rilpivirine—ABCB1—Sunitinib—kidney cancer	0.00187	0.00755	CbGbCtD
Rilpivirine—CYP3A4—Erlotinib—kidney cancer	0.0017	0.00687	CbGbCtD
Rilpivirine—CYP3A4—Paclitaxel—kidney cancer	0.00156	0.00629	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—kidney cancer	0.0014	0.00566	CbGbCtD
Rilpivirine—CYP3A4—Sorafenib—kidney cancer	0.00138	0.00559	CbGbCtD
Rilpivirine—CYP3A4—Vinblastine—kidney cancer	0.00137	0.00552	CbGbCtD
Rilpivirine—CYP3A4—Vincristine—kidney cancer	0.00134	0.00542	CbGbCtD
Rilpivirine—CYP3A4—Sunitinib—kidney cancer	0.00112	0.00453	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—kidney cancer	0.00084	0.00339	CbGbCtD
Rilpivirine—Pazopanib—FLT1—kidney cancer	0.000792	0.375	CrCbGaD
Rilpivirine—Pazopanib—KDR—kidney cancer	0.000497	0.235	CrCbGaD
Rilpivirine—Pazopanib—KIT—kidney cancer	0.000469	0.222	CrCbGaD
Rilpivirine—Etravirine—ABCB1—kidney cancer	0.000248	0.117	CrCbGaD
Rilpivirine—CYP2C19—urine—kidney cancer	0.000218	0.195	CbGeAlD
Rilpivirine—CYP1A2—urine—kidney cancer	0.000178	0.159	CbGeAlD
Rilpivirine—CYP3A4—urine—kidney cancer	0.000129	0.115	CbGeAlD
Rilpivirine—Pazopanib—ABCB1—kidney cancer	0.000108	0.0511	CrCbGaD
Rilpivirine—Malnutrition—Sunitinib—kidney cancer	9.39e-05	0.00159	CcSEcCtD
Rilpivirine—Dry mouth—Everolimus—kidney cancer	9.36e-05	0.00158	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Paclitaxel—kidney cancer	9.23e-05	0.00156	CcSEcCtD
Rilpivirine—Anxiety—Erlotinib—kidney cancer	9.2e-05	0.00156	CcSEcCtD
Rilpivirine—Abdominal pain—Pazopanib—kidney cancer	9.18e-05	0.00156	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	9.17e-05	0.00155	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Gemcitabine—kidney cancer	9.11e-05	0.00154	CcSEcCtD
Rilpivirine—Infection—Everolimus—kidney cancer	9.11e-05	0.00154	CcSEcCtD
Rilpivirine—Renal impairment—Capecitabine—kidney cancer	9.03e-05	0.00153	CcSEcCtD
Rilpivirine—Urinary tract disorder—Vincristine—kidney cancer	9.01e-05	0.00153	CcSEcCtD
Rilpivirine—Nervous system disorder—Everolimus—kidney cancer	8.99e-05	0.00152	CcSEcCtD
Rilpivirine—Urethral disorder—Vincristine—kidney cancer	8.94e-05	0.00151	CcSEcCtD
Rilpivirine—Skin disorder—Everolimus—kidney cancer	8.91e-05	0.00151	CcSEcCtD
Rilpivirine—Asthenia—Temsirolimus—kidney cancer	8.85e-05	0.0015	CcSEcCtD
Rilpivirine—Infection—Erlotinib—kidney cancer	8.79e-05	0.00149	CcSEcCtD
Rilpivirine—Nervous system disorder—Erlotinib—kidney cancer	8.68e-05	0.00147	CcSEcCtD
Rilpivirine—Skin disorder—Erlotinib—kidney cancer	8.59e-05	0.00146	CcSEcCtD
Rilpivirine—Urinary tract disorder—Gemcitabine—kidney cancer	8.54e-05	0.00145	CcSEcCtD
Rilpivirine—Urethral disorder—Gemcitabine—kidney cancer	8.48e-05	0.00144	CcSEcCtD
Rilpivirine—Diarrhoea—Temsirolimus—kidney cancer	8.44e-05	0.00143	CcSEcCtD
Rilpivirine—Asthenia—Pazopanib—kidney cancer	8.33e-05	0.00141	CcSEcCtD
Rilpivirine—Insomnia—Everolimus—kidney cancer	8.29e-05	0.0014	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	8.25e-05	0.0014	CcSEcCtD
Rilpivirine—SLCO1B1—renal system—kidney cancer	8.18e-05	0.0733	CbGeAlD
Rilpivirine—Somnolence—Everolimus—kidney cancer	8.15e-05	0.00138	CcSEcCtD
Rilpivirine—Dizziness—Temsirolimus—kidney cancer	8.15e-05	0.00138	CcSEcCtD
Rilpivirine—Dry mouth—Sorafenib—kidney cancer	8.12e-05	0.00138	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—kidney cancer	8.07e-05	0.00137	CcSEcCtD
Rilpivirine—Blood creatinine increased—Capecitabine—kidney cancer	8.05e-05	0.00136	CcSEcCtD
Rilpivirine—Depression—Paclitaxel—kidney cancer	8.05e-05	0.00136	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—kidney cancer	8.02e-05	0.00136	CcSEcCtD
Rilpivirine—Insomnia—Erlotinib—kidney cancer	8e-05	0.00136	CcSEcCtD
Rilpivirine—Decreased appetite—Vinblastine—kidney cancer	8e-05	0.00136	CcSEcCtD
Rilpivirine—Mental disorder—Vincristine—kidney cancer	7.99e-05	0.00135	CcSEcCtD
Rilpivirine—Decreased appetite—Everolimus—kidney cancer	7.97e-05	0.00135	CcSEcCtD
Rilpivirine—Diarrhoea—Pazopanib—kidney cancer	7.95e-05	0.00135	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	7.94e-05	0.00134	CcSEcCtD
Rilpivirine—Renal failure—Paclitaxel—kidney cancer	7.93e-05	0.00134	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Everolimus—kidney cancer	7.92e-05	0.00134	CcSEcCtD
Rilpivirine—SLCO1B1—kidney—kidney cancer	7.91e-05	0.0709	CbGeAlD
Rilpivirine—Infection—Sorafenib—kidney cancer	7.91e-05	0.00134	CcSEcCtD
Rilpivirine—Fatigue—Everolimus—kidney cancer	7.91e-05	0.00134	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—kidney cancer	7.87e-05	0.00133	CcSEcCtD
Rilpivirine—Vomiting—Temsirolimus—kidney cancer	7.84e-05	0.00133	CcSEcCtD
Rilpivirine—Dry mouth—Sunitinib—kidney cancer	7.81e-05	0.00132	CcSEcCtD
Rilpivirine—Immune system disorder—Gemcitabine—kidney cancer	7.81e-05	0.00132	CcSEcCtD
Rilpivirine—Nervous system disorder—Sorafenib—kidney cancer	7.81e-05	0.00132	CcSEcCtD
Rilpivirine—Rash—Temsirolimus—kidney cancer	7.77e-05	0.00132	CcSEcCtD
Rilpivirine—Dermatitis—Temsirolimus—kidney cancer	7.77e-05	0.00132	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Capecitabine—kidney cancer	7.74e-05	0.00131	CcSEcCtD
Rilpivirine—Skin disorder—Sorafenib—kidney cancer	7.73e-05	0.00131	CcSEcCtD
Rilpivirine—Headache—Temsirolimus—kidney cancer	7.72e-05	0.00131	CcSEcCtD
Rilpivirine—Decreased appetite—Erlotinib—kidney cancer	7.69e-05	0.0013	CcSEcCtD
Rilpivirine—Dizziness—Pazopanib—kidney cancer	7.68e-05	0.0013	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Erlotinib—kidney cancer	7.64e-05	0.00129	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Paclitaxel—kidney cancer	7.63e-05	0.00129	CcSEcCtD
Rilpivirine—Fatigue—Erlotinib—kidney cancer	7.63e-05	0.00129	CcSEcCtD
Rilpivirine—Infection—Sunitinib—kidney cancer	7.61e-05	0.00129	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Capecitabine—kidney cancer	7.58e-05	0.00128	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—kidney cancer	7.54e-05	0.00128	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vinblastine—kidney cancer	7.53e-05	0.00128	CcSEcCtD
Rilpivirine—Nervous system disorder—Sunitinib—kidney cancer	7.51e-05	0.00127	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Everolimus—kidney cancer	7.5e-05	0.00127	CcSEcCtD
Rilpivirine—Skin disorder—Sunitinib—kidney cancer	7.44e-05	0.00126	CcSEcCtD
Rilpivirine—Vomiting—Pazopanib—kidney cancer	7.39e-05	0.00125	CcSEcCtD
Rilpivirine—Rash—Pazopanib—kidney cancer	7.32e-05	0.00124	CcSEcCtD
Rilpivirine—Nausea—Temsirolimus—kidney cancer	7.32e-05	0.00124	CcSEcCtD
Rilpivirine—Dermatitis—Pazopanib—kidney cancer	7.32e-05	0.00124	CcSEcCtD
Rilpivirine—Abdominal pain—Vinblastine—kidney cancer	7.28e-05	0.00123	CcSEcCtD
Rilpivirine—Headache—Pazopanib—kidney cancer	7.28e-05	0.00123	CcSEcCtD
Rilpivirine—Abdominal pain—Everolimus—kidney cancer	7.25e-05	0.00123	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Erlotinib—kidney cancer	7.24e-05	0.00123	CcSEcCtD
Rilpivirine—Infection—Dactinomycin—kidney cancer	7.2e-05	0.00122	CcSEcCtD
Rilpivirine—Urinary tract disorder—Paclitaxel—kidney cancer	7.15e-05	0.00121	CcSEcCtD
Rilpivirine—Abdominal discomfort—Capecitabine—kidney cancer	7.12e-05	0.00121	CcSEcCtD
Rilpivirine—Urethral disorder—Paclitaxel—kidney cancer	7.1e-05	0.0012	CcSEcCtD
Rilpivirine—Abdominal pain—Erlotinib—kidney cancer	7e-05	0.00118	CcSEcCtD
Rilpivirine—Insomnia—Sunitinib—kidney cancer	6.93e-05	0.00117	CcSEcCtD
Rilpivirine—Decreased appetite—Sorafenib—kidney cancer	6.92e-05	0.00117	CcSEcCtD
Rilpivirine—Nausea—Pazopanib—kidney cancer	6.9e-05	0.00117	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Sorafenib—kidney cancer	6.87e-05	0.00116	CcSEcCtD
Rilpivirine—Fatigue—Sorafenib—kidney cancer	6.86e-05	0.00116	CcSEcCtD
Rilpivirine—Decreased appetite—Sunitinib—kidney cancer	6.66e-05	0.00113	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Sunitinib—kidney cancer	6.61e-05	0.00112	CcSEcCtD
Rilpivirine—Asthenia—Vinblastine—kidney cancer	6.61e-05	0.00112	CcSEcCtD
Rilpivirine—Fatigue—Sunitinib—kidney cancer	6.6e-05	0.00112	CcSEcCtD
Rilpivirine—Depression—Capecitabine—kidney cancer	6.6e-05	0.00112	CcSEcCtD
Rilpivirine—Asthenia—Everolimus—kidney cancer	6.58e-05	0.00111	CcSEcCtD
Rilpivirine—Immune system disorder—Paclitaxel—kidney cancer	6.54e-05	0.00111	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Sorafenib—kidney cancer	6.51e-05	0.0011	CcSEcCtD
Rilpivirine—Renal failure—Capecitabine—kidney cancer	6.51e-05	0.0011	CcSEcCtD
Rilpivirine—Infection—Vincristine—kidney cancer	6.44e-05	0.00109	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	6.37e-05	0.00108	CcSEcCtD
Rilpivirine—Nervous system disorder—Vincristine—kidney cancer	6.35e-05	0.00108	CcSEcCtD
Rilpivirine—Asthenia—Erlotinib—kidney cancer	6.35e-05	0.00108	CcSEcCtD
Rilpivirine—Mental disorder—Paclitaxel—kidney cancer	6.35e-05	0.00107	CcSEcCtD
Rilpivirine—Malnutrition—Paclitaxel—kidney cancer	6.31e-05	0.00107	CcSEcCtD
Rilpivirine—Decreased appetite—Dactinomycin—kidney cancer	6.3e-05	0.00107	CcSEcCtD
Rilpivirine—Diarrhoea—Vinblastine—kidney cancer	6.3e-05	0.00107	CcSEcCtD
Rilpivirine—Abdominal pain—Sorafenib—kidney cancer	6.29e-05	0.00107	CcSEcCtD
Rilpivirine—Diarrhoea—Everolimus—kidney cancer	6.27e-05	0.00106	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Sunitinib—kidney cancer	6.26e-05	0.00106	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Capecitabine—kidney cancer	6.26e-05	0.00106	CcSEcCtD
Rilpivirine—Fatigue—Dactinomycin—kidney cancer	6.25e-05	0.00106	CcSEcCtD
Rilpivirine—Infection—Gemcitabine—kidney cancer	6.11e-05	0.00103	CcSEcCtD
Rilpivirine—Dizziness—Vinblastine—kidney cancer	6.09e-05	0.00103	CcSEcCtD
Rilpivirine—Dizziness—Everolimus—kidney cancer	6.06e-05	0.00103	CcSEcCtD
Rilpivirine—Abdominal pain—Sunitinib—kidney cancer	6.06e-05	0.00103	CcSEcCtD
Rilpivirine—Diarrhoea—Erlotinib—kidney cancer	6.05e-05	0.00103	CcSEcCtD
Rilpivirine—Nervous system disorder—Gemcitabine—kidney cancer	6.03e-05	0.00102	CcSEcCtD
Rilpivirine—Skin disorder—Gemcitabine—kidney cancer	5.97e-05	0.00101	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dactinomycin—kidney cancer	5.93e-05	0.001	CcSEcCtD
Rilpivirine—Urinary tract disorder—Capecitabine—kidney cancer	5.87e-05	0.000994	CcSEcCtD
Rilpivirine—Insomnia—Vincristine—kidney cancer	5.86e-05	0.000992	CcSEcCtD
Rilpivirine—Vomiting—Vinblastine—kidney cancer	5.85e-05	0.000991	CcSEcCtD
Rilpivirine—Dizziness—Erlotinib—kidney cancer	5.85e-05	0.000991	CcSEcCtD
Rilpivirine—Vomiting—Everolimus—kidney cancer	5.83e-05	0.000988	CcSEcCtD
Rilpivirine—Urethral disorder—Capecitabine—kidney cancer	5.83e-05	0.000987	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—kidney cancer	5.82e-05	0.000986	CcSEcCtD
Rilpivirine—Rash—Everolimus—kidney cancer	5.78e-05	0.000979	CcSEcCtD
Rilpivirine—Dermatitis—Everolimus—kidney cancer	5.78e-05	0.000978	CcSEcCtD
Rilpivirine—Headache—Vinblastine—kidney cancer	5.77e-05	0.000977	CcSEcCtD
Rilpivirine—Headache—Everolimus—kidney cancer	5.75e-05	0.000973	CcSEcCtD
Rilpivirine—Abdominal pain—Dactinomycin—kidney cancer	5.73e-05	0.000971	CcSEcCtD
Rilpivirine—Asthenia—Sorafenib—kidney cancer	5.71e-05	0.000967	CcSEcCtD
Rilpivirine—Decreased appetite—Vincristine—kidney cancer	5.63e-05	0.000954	CcSEcCtD
Rilpivirine—Vomiting—Erlotinib—kidney cancer	5.63e-05	0.000953	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vincristine—kidney cancer	5.59e-05	0.000947	CcSEcCtD
Rilpivirine—Fatigue—Vincristine—kidney cancer	5.59e-05	0.000946	CcSEcCtD
Rilpivirine—Rash—Erlotinib—kidney cancer	5.58e-05	0.000945	CcSEcCtD
Rilpivirine—Dermatitis—Erlotinib—kidney cancer	5.57e-05	0.000944	CcSEcCtD
Rilpivirine—Insomnia—Gemcitabine—kidney cancer	5.56e-05	0.000942	CcSEcCtD
Rilpivirine—Headache—Erlotinib—kidney cancer	5.54e-05	0.000939	CcSEcCtD
Rilpivirine—Asthenia—Sunitinib—kidney cancer	5.5e-05	0.000931	CcSEcCtD
Rilpivirine—Nausea—Vinblastine—kidney cancer	5.47e-05	0.000926	CcSEcCtD
Rilpivirine—Somnolence—Gemcitabine—kidney cancer	5.46e-05	0.000925	CcSEcCtD
Rilpivirine—Nausea—Everolimus—kidney cancer	5.45e-05	0.000923	CcSEcCtD
Rilpivirine—Diarrhoea—Sorafenib—kidney cancer	5.45e-05	0.000922	CcSEcCtD
Rilpivirine—Immune system disorder—Capecitabine—kidney cancer	5.37e-05	0.000909	CcSEcCtD
Rilpivirine—Anxiety—Paclitaxel—kidney cancer	5.35e-05	0.000906	CcSEcCtD
Rilpivirine—Decreased appetite—Gemcitabine—kidney cancer	5.34e-05	0.000905	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	5.33e-05	0.000903	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Gemcitabine—kidney cancer	5.31e-05	0.000899	CcSEcCtD
Rilpivirine—Fatigue—Gemcitabine—kidney cancer	5.3e-05	0.000897	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vincristine—kidney cancer	5.3e-05	0.000897	CcSEcCtD
Rilpivirine—Dizziness—Sorafenib—kidney cancer	5.26e-05	0.000892	CcSEcCtD
Rilpivirine—Nausea—Erlotinib—kidney cancer	5.26e-05	0.00089	CcSEcCtD
Rilpivirine—Dry mouth—Paclitaxel—kidney cancer	5.25e-05	0.000889	CcSEcCtD
Rilpivirine—Diarrhoea—Sunitinib—kidney cancer	5.24e-05	0.000888	CcSEcCtD
Rilpivirine—Mental disorder—Capecitabine—kidney cancer	5.21e-05	0.000882	CcSEcCtD
Rilpivirine—Asthenia—Dactinomycin—kidney cancer	5.2e-05	0.000881	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—kidney cancer	5.19e-05	0.000879	CcSEcCtD
Rilpivirine—Malnutrition—Capecitabine—kidney cancer	5.17e-05	0.000876	CcSEcCtD
Rilpivirine—Abdominal pain—Vincristine—kidney cancer	5.12e-05	0.000867	CcSEcCtD
Rilpivirine—Infection—Paclitaxel—kidney cancer	5.11e-05	0.000866	CcSEcCtD
Rilpivirine—Dizziness—Sunitinib—kidney cancer	5.07e-05	0.000858	CcSEcCtD
Rilpivirine—Vomiting—Sorafenib—kidney cancer	5.06e-05	0.000857	CcSEcCtD
Rilpivirine—Nervous system disorder—Paclitaxel—kidney cancer	5.05e-05	0.000855	CcSEcCtD
Rilpivirine—Rash—Sorafenib—kidney cancer	5.02e-05	0.00085	CcSEcCtD
Rilpivirine—Dermatitis—Sorafenib—kidney cancer	5.01e-05	0.000849	CcSEcCtD
Rilpivirine—Skin disorder—Paclitaxel—kidney cancer	5e-05	0.000847	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.99e-05	0.000845	CcSEcCtD
Rilpivirine—Headache—Sorafenib—kidney cancer	4.99e-05	0.000845	CcSEcCtD
Rilpivirine—ABCG2—nephron tubule—kidney cancer	4.98e-05	0.0446	CbGeAlD
Rilpivirine—Diarrhoea—Dactinomycin—kidney cancer	4.96e-05	0.00084	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.88e-05	0.000827	CcSEcCtD
Rilpivirine—Vomiting—Sunitinib—kidney cancer	4.87e-05	0.000825	CcSEcCtD
Rilpivirine—Rash—Sunitinib—kidney cancer	4.83e-05	0.000818	CcSEcCtD
Rilpivirine—Dermatitis—Sunitinib—kidney cancer	4.83e-05	0.000817	CcSEcCtD
Rilpivirine—Headache—Sunitinib—kidney cancer	4.8e-05	0.000813	CcSEcCtD
Rilpivirine—Nausea—Sorafenib—kidney cancer	4.73e-05	0.000801	CcSEcCtD
Rilpivirine—Insomnia—Paclitaxel—kidney cancer	4.65e-05	0.000788	CcSEcCtD
Rilpivirine—Asthenia—Vincristine—kidney cancer	4.65e-05	0.000787	CcSEcCtD
Rilpivirine—Vomiting—Dactinomycin—kidney cancer	4.61e-05	0.000781	CcSEcCtD
Rilpivirine—CYP2B6—nephron tubule—kidney cancer	4.59e-05	0.0411	CbGeAlD
Rilpivirine—Somnolence—Paclitaxel—kidney cancer	4.57e-05	0.000775	CcSEcCtD
Rilpivirine—Rash—Dactinomycin—kidney cancer	4.57e-05	0.000774	CcSEcCtD
Rilpivirine—Nausea—Sunitinib—kidney cancer	4.55e-05	0.000771	CcSEcCtD
Rilpivirine—Decreased appetite—Paclitaxel—kidney cancer	4.47e-05	0.000758	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.44e-05	0.000752	CcSEcCtD
Rilpivirine—Fatigue—Paclitaxel—kidney cancer	4.44e-05	0.000751	CcSEcCtD
Rilpivirine—Diarrhoea—Vincristine—kidney cancer	4.43e-05	0.000751	CcSEcCtD
Rilpivirine—Asthenia—Gemcitabine—kidney cancer	4.41e-05	0.000747	CcSEcCtD
Rilpivirine—Anxiety—Capecitabine—kidney cancer	4.39e-05	0.000744	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.37e-05	0.000741	CcSEcCtD
Rilpivirine—CYP1A2—renal system—kidney cancer	4.35e-05	0.039	CbGeAlD
Rilpivirine—Dry mouth—Capecitabine—kidney cancer	4.31e-05	0.00073	CcSEcCtD
Rilpivirine—Nausea—Dactinomycin—kidney cancer	4.31e-05	0.00073	CcSEcCtD
Rilpivirine—Dizziness—Vincristine—kidney cancer	4.28e-05	0.000726	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Paclitaxel—kidney cancer	4.21e-05	0.000713	CcSEcCtD
Rilpivirine—Diarrhoea—Gemcitabine—kidney cancer	4.21e-05	0.000712	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—kidney cancer	4.2e-05	0.000711	CcSEcCtD
Rilpivirine—Infection—Capecitabine—kidney cancer	4.2e-05	0.000711	CcSEcCtD
Rilpivirine—CYP2B6—renal system—kidney cancer	4.17e-05	0.0374	CbGeAlD
Rilpivirine—Nervous system disorder—Capecitabine—kidney cancer	4.14e-05	0.000701	CcSEcCtD
Rilpivirine—Vomiting—Vincristine—kidney cancer	4.12e-05	0.000698	CcSEcCtD
Rilpivirine—Skin disorder—Capecitabine—kidney cancer	4.1e-05	0.000695	CcSEcCtD
Rilpivirine—Rash—Vincristine—kidney cancer	4.09e-05	0.000692	CcSEcCtD
Rilpivirine—Dermatitis—Vincristine—kidney cancer	4.08e-05	0.000691	CcSEcCtD
Rilpivirine—Abdominal pain—Paclitaxel—kidney cancer	4.07e-05	0.000689	CcSEcCtD
Rilpivirine—Headache—Vincristine—kidney cancer	4.06e-05	0.000687	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—kidney cancer	4.04e-05	0.000684	CcSEcCtD
Rilpivirine—CYP2B6—kidney—kidney cancer	4.04e-05	0.0362	CbGeAlD
Rilpivirine—Vomiting—Gemcitabine—kidney cancer	3.91e-05	0.000662	CcSEcCtD
Rilpivirine—Rash—Gemcitabine—kidney cancer	3.88e-05	0.000656	CcSEcCtD
Rilpivirine—Dermatitis—Gemcitabine—kidney cancer	3.87e-05	0.000656	CcSEcCtD
Rilpivirine—Headache—Gemcitabine—kidney cancer	3.85e-05	0.000652	CcSEcCtD
Rilpivirine—Nausea—Vincristine—kidney cancer	3.85e-05	0.000652	CcSEcCtD
Rilpivirine—Insomnia—Capecitabine—kidney cancer	3.82e-05	0.000647	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—kidney cancer	3.78e-05	0.000641	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—kidney cancer	3.76e-05	0.000636	CcSEcCtD
Rilpivirine—CYP2B6—gonad—kidney cancer	3.74e-05	0.0335	CbGeAlD
Rilpivirine—Asthenia—Paclitaxel—kidney cancer	3.69e-05	0.000625	CcSEcCtD
Rilpivirine—Decreased appetite—Capecitabine—kidney cancer	3.67e-05	0.000622	CcSEcCtD
Rilpivirine—Nausea—Gemcitabine—kidney cancer	3.65e-05	0.000618	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Capecitabine—kidney cancer	3.65e-05	0.000617	CcSEcCtD
Rilpivirine—Fatigue—Capecitabine—kidney cancer	3.64e-05	0.000617	CcSEcCtD
Rilpivirine—Diarrhoea—Paclitaxel—kidney cancer	3.52e-05	0.000596	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—kidney cancer	3.46e-05	0.000586	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Capecitabine—kidney cancer	3.45e-05	0.000585	CcSEcCtD
Rilpivirine—Dizziness—Paclitaxel—kidney cancer	3.4e-05	0.000576	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—kidney cancer	3.36e-05	0.000569	CcSEcCtD
Rilpivirine—Abdominal pain—Capecitabine—kidney cancer	3.34e-05	0.000565	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—kidney cancer	3.34e-05	0.000565	CcSEcCtD
Rilpivirine—Vomiting—Paclitaxel—kidney cancer	3.27e-05	0.000554	CcSEcCtD
Rilpivirine—Rash—Paclitaxel—kidney cancer	3.24e-05	0.00055	CcSEcCtD
Rilpivirine—Dermatitis—Paclitaxel—kidney cancer	3.24e-05	0.000549	CcSEcCtD
Rilpivirine—Headache—Paclitaxel—kidney cancer	3.22e-05	0.000546	CcSEcCtD
Rilpivirine—CYP3A4—renal system—kidney cancer	3.15e-05	0.0282	CbGeAlD
Rilpivirine—Nausea—Paclitaxel—kidney cancer	3.06e-05	0.000518	CcSEcCtD
Rilpivirine—CYP3A4—kidney—kidney cancer	3.05e-05	0.0273	CbGeAlD
Rilpivirine—Asthenia—Capecitabine—kidney cancer	3.03e-05	0.000513	CcSEcCtD
Rilpivirine—Diarrhoea—Capecitabine—kidney cancer	2.89e-05	0.000489	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—kidney cancer	2.83e-05	0.000479	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.82e-05	0.000478	CcSEcCtD
Rilpivirine—Dizziness—Capecitabine—kidney cancer	2.79e-05	0.000473	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—kidney cancer	2.78e-05	0.00047	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—kidney cancer	2.7e-05	0.000458	CcSEcCtD
Rilpivirine—Vomiting—Capecitabine—kidney cancer	2.69e-05	0.000455	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—kidney cancer	2.67e-05	0.000452	CcSEcCtD
Rilpivirine—Rash—Capecitabine—kidney cancer	2.66e-05	0.000451	CcSEcCtD
Rilpivirine—Dermatitis—Capecitabine—kidney cancer	2.66e-05	0.000451	CcSEcCtD
Rilpivirine—Headache—Capecitabine—kidney cancer	2.65e-05	0.000448	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—kidney cancer	2.64e-05	0.000448	CcSEcCtD
Rilpivirine—Nausea—Capecitabine—kidney cancer	2.51e-05	0.000425	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—kidney cancer	2.46e-05	0.000417	CcSEcCtD
Rilpivirine—ABCB1—nephron tubule—kidney cancer	2.45e-05	0.022	CbGeAlD
Rilpivirine—Somnolence—Doxorubicin—kidney cancer	2.42e-05	0.00041	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—kidney cancer	2.37e-05	0.000401	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.35e-05	0.000398	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—kidney cancer	2.35e-05	0.000397	CcSEcCtD
Rilpivirine—ABCB1—renal system—kidney cancer	2.23e-05	0.02	CbGeAlD
Rilpivirine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.23e-05	0.000377	CcSEcCtD
Rilpivirine—ABCB1—kidney—kidney cancer	2.16e-05	0.0193	CbGeAlD
Rilpivirine—Abdominal pain—Doxorubicin—kidney cancer	2.15e-05	0.000364	CcSEcCtD
Rilpivirine—ABCB1—cortex of kidney—kidney cancer	2.1e-05	0.0188	CbGeAlD
Rilpivirine—ABCB1—gonad—kidney cancer	2e-05	0.0179	CbGeAlD
Rilpivirine—Asthenia—Doxorubicin—kidney cancer	1.95e-05	0.000331	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—kidney cancer	1.86e-05	0.000315	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—kidney cancer	1.8e-05	0.000305	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—kidney cancer	1.73e-05	0.000293	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—kidney cancer	1.72e-05	0.000291	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—kidney cancer	1.71e-05	0.00029	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—kidney cancer	1.71e-05	0.000289	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—kidney cancer	1.62e-05	0.000274	CcSEcCtD
Rilpivirine—CYP2B6—Metabolism—ST3GAL2—kidney cancer	6.12e-06	0.000525	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—RAF1—kidney cancer	6.11e-06	0.000524	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CRABP1—kidney cancer	6.11e-06	0.000524	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALDH1A1—kidney cancer	5.98e-06	0.000513	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.96e-06	0.000512	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.95e-06	0.000511	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.86e-06	0.000504	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC5A3—kidney cancer	5.73e-06	0.000492	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PGK1—kidney cancer	5.73e-06	0.000492	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GLIPR1—kidney cancer	5.72e-06	0.000491	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPAT—kidney cancer	5.72e-06	0.000491	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ITPR2—kidney cancer	5.68e-06	0.000487	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CRABP1—kidney cancer	5.65e-06	0.000485	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.64e-06	0.000485	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.64e-06	0.000484	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—LDHB—kidney cancer	5.62e-06	0.000483	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.59e-06	0.00048	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPAT—kidney cancer	5.58e-06	0.000479	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GLIPR1—kidney cancer	5.58e-06	0.000479	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.56e-06	0.000477	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.48e-06	0.00047	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PDHB—kidney cancer	5.46e-06	0.000469	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—POMC—kidney cancer	5.45e-06	0.000468	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.42e-06	0.000465	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTP1—kidney cancer	5.34e-06	0.000458	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APRT—kidney cancer	5.31e-06	0.000456	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—FH—kidney cancer	5.31e-06	0.000456	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ITPR2—kidney cancer	5.26e-06	0.000451	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.23e-06	0.000449	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.19e-06	0.000446	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APRT—kidney cancer	5.19e-06	0.000445	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—FH—kidney cancer	5.19e-06	0.000445	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTT1—kidney cancer	5.18e-06	0.000444	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ACHE—kidney cancer	5.18e-06	0.000444	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5.17e-06	0.000444	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CCBL1—kidney cancer	5.14e-06	0.000441	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	5.12e-06	0.000439	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ABCB1—kidney cancer	5.06e-06	0.000434	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	5e-06	0.00043	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GPC3—kidney cancer	5e-06	0.000429	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ACY1—kidney cancer	4.96e-06	0.000426	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTM1—kidney cancer	4.91e-06	0.000421	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SCARB1—kidney cancer	4.9e-06	0.000421	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GPC3—kidney cancer	4.88e-06	0.000419	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CA9—kidney cancer	4.87e-06	0.000418	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA2—kidney cancer	4.86e-06	0.000417	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS1—kidney cancer	4.85e-06	0.000416	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTT1—kidney cancer	4.79e-06	0.000412	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ACHE—kidney cancer	4.79e-06	0.000412	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.76e-06	0.000409	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PSMD7—kidney cancer	4.76e-06	0.000408	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MAPK3—kidney cancer	4.75e-06	0.000408	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA2—kidney cancer	4.74e-06	0.000407	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.74e-06	0.000407	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALAD—kidney cancer	4.74e-06	0.000407	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP1A1—kidney cancer	4.65e-06	0.000399	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.65e-06	0.000399	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	4.62e-06	0.000397	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALAD—kidney cancer	4.62e-06	0.000397	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—kidney cancer	4.62e-06	0.000397	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.6e-06	0.000395	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SCARB1—kidney cancer	4.54e-06	0.00039	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.52e-06	0.000388	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	4.52e-06	0.000388	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ST3GAL2—kidney cancer	4.51e-06	0.000387	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.51e-06	0.000387	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—BCHE—kidney cancer	4.51e-06	0.000387	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS1—kidney cancer	4.49e-06	0.000386	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.48e-06	0.000384	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC5A5—kidney cancer	4.45e-06	0.000382	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPAT—kidney cancer	4.45e-06	0.000382	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GLIPR1—kidney cancer	4.45e-06	0.000382	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALDH1A1—kidney cancer	4.41e-06	0.000379	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PSMD7—kidney cancer	4.4e-06	0.000378	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.4e-06	0.000378	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.36e-06	0.000375	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.35e-06	0.000374	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PGK1—kidney cancer	4.33e-06	0.000372	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC5A3—kidney cancer	4.33e-06	0.000372	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC2A1—kidney cancer	4.3e-06	0.000369	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LDHB—kidney cancer	4.25e-06	0.000365	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PGK1—kidney cancer	4.23e-06	0.000363	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC5A3—kidney cancer	4.23e-06	0.000363	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PDHB—kidney cancer	4.22e-06	0.000362	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—POMC—kidney cancer	4.2e-06	0.000361	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—BCHE—kidney cancer	4.18e-06	0.000358	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.17e-06	0.000358	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LDHB—kidney cancer	4.15e-06	0.000356	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CRABP1—kidney cancer	4.14e-06	0.000356	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APRT—kidney cancer	4.14e-06	0.000355	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—FH—kidney cancer	4.14e-06	0.000355	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC5A5—kidney cancer	4.12e-06	0.000354	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.1e-06	0.000352	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.05e-06	0.000347	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC2A1—kidney cancer	3.98e-06	0.000342	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CCBL1—kidney cancer	3.96e-06	0.00034	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.94e-06	0.000338	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GPC3—kidney cancer	3.89e-06	0.000334	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ITPR2—kidney cancer	3.85e-06	0.000331	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.82e-06	0.000328	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.8e-06	0.000326	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA2—kidney cancer	3.79e-06	0.000325	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.73e-06	0.00032	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALAD—kidney cancer	3.69e-06	0.000317	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA9—kidney cancer	3.68e-06	0.000316	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.64e-06	0.000313	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.63e-06	0.000311	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.6e-06	0.000309	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.6e-06	0.000309	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA9—kidney cancer	3.59e-06	0.000309	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTP1—kidney cancer	3.59e-06	0.000308	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.55e-06	0.000305	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.52e-06	0.000302	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTT1—kidney cancer	3.51e-06	0.000302	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ACHE—kidney cancer	3.51e-06	0.000302	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—POMC—kidney cancer	3.47e-06	0.000298	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.44e-06	0.000295	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPAT—kidney cancer	3.44e-06	0.000295	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCB1—kidney cancer	3.4e-06	0.000292	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC5A3—kidney cancer	3.38e-06	0.00029	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PGK1—kidney cancer	3.38e-06	0.00029	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.35e-06	0.000288	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SCARB1—kidney cancer	3.33e-06	0.000286	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTP1—kidney cancer	3.32e-06	0.000285	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LDHB—kidney cancer	3.31e-06	0.000284	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—kidney cancer	3.3e-06	0.000283	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS1—kidney cancer	3.29e-06	0.000283	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PSMD7—kidney cancer	3.23e-06	0.000277	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APRT—kidney cancer	3.2e-06	0.000274	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—FH—kidney cancer	3.2e-06	0.000274	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCB1—kidney cancer	3.14e-06	0.00027	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CRABP1—kidney cancer	3.13e-06	0.000269	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1A1—kidney cancer	3.13e-06	0.000268	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.08e-06	0.000264	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—BCHE—kidney cancer	3.06e-06	0.000263	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CRABP1—kidney cancer	3.06e-06	0.000262	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—kidney cancer	3.05e-06	0.000262	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC5A5—kidney cancer	3.02e-06	0.00026	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GPC3—kidney cancer	3e-06	0.000258	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.98e-06	0.000256	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA2—kidney cancer	2.92e-06	0.000251	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.92e-06	0.000251	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ITPR2—kidney cancer	2.91e-06	0.00025	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1A1—kidney cancer	2.89e-06	0.000248	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA9—kidney cancer	2.87e-06	0.000246	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALAD—kidney cancer	2.85e-06	0.000245	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ITPR2—kidney cancer	2.84e-06	0.000244	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.8e-06	0.000241	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.78e-06	0.000239	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—kidney cancer	2.77e-06	0.000238	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.72e-06	0.000233	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.68e-06	0.00023	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—kidney cancer	2.65e-06	0.000228	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ACHE—kidney cancer	2.65e-06	0.000228	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PGK1—kidney cancer	2.6e-06	0.000224	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.6e-06	0.000224	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ACHE—kidney cancer	2.59e-06	0.000222	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—kidney cancer	2.59e-06	0.000222	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.57e-06	0.00022	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LDHB—kidney cancer	2.55e-06	0.000219	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SCARB1—kidney cancer	2.51e-06	0.000216	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS1—kidney cancer	2.49e-06	0.000214	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SCARB1—kidney cancer	2.45e-06	0.000211	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CRABP1—kidney cancer	2.44e-06	0.00021	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PSMD7—kidney cancer	2.44e-06	0.000209	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—kidney cancer	2.44e-06	0.000209	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS1—kidney cancer	2.43e-06	0.000208	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—kidney cancer	2.41e-06	0.000207	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PSMD7—kidney cancer	2.38e-06	0.000204	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—POMC—kidney cancer	2.33e-06	0.0002	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—BCHE—kidney cancer	2.31e-06	0.000199	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—kidney cancer	2.31e-06	0.000198	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.28e-06	0.000196	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ITPR2—kidney cancer	2.27e-06	0.000195	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—BCHE—kidney cancer	2.26e-06	0.000194	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—kidney cancer	2.24e-06	0.000192	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC5A5—kidney cancer	2.23e-06	0.000191	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA9—kidney cancer	2.21e-06	0.00019	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.21e-06	0.000189	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—POMC—kidney cancer	2.16e-06	0.000185	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC2A1—kidney cancer	2.15e-06	0.000185	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.14e-06	0.000184	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.12e-06	0.000182	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.09e-06	0.00018	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—kidney cancer	2.07e-06	0.000178	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ACHE—kidney cancer	2.07e-06	0.000178	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.05e-06	0.000176	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SCARB1—kidney cancer	1.96e-06	0.000168	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS1—kidney cancer	1.94e-06	0.000166	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PSMD7—kidney cancer	1.9e-06	0.000163	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.88e-06	0.000162	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.87e-06	0.00016	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—kidney cancer	1.86e-06	0.00016	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—kidney cancer	1.84e-06	0.000158	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—BCHE—kidney cancer	1.8e-06	0.000155	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—kidney cancer	1.8e-06	0.000154	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.78e-06	0.000153	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.75e-06	0.00015	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—kidney cancer	1.74e-06	0.00015	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—kidney cancer	1.72e-06	0.000148	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.72e-06	0.000148	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—kidney cancer	1.7e-06	0.000146	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—kidney cancer	1.69e-06	0.000145	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.67e-06	0.000143	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—kidney cancer	1.65e-06	0.000142	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—kidney cancer	1.62e-06	0.000139	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.6e-06	0.000138	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—kidney cancer	1.6e-06	0.000137	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ACHE—kidney cancer	1.6e-06	0.000137	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—POMC—kidney cancer	1.58e-06	0.000136	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1A1—kidney cancer	1.56e-06	0.000134	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SCARB1—kidney cancer	1.51e-06	0.00013	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—kidney cancer	1.5e-06	0.000129	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS1—kidney cancer	1.5e-06	0.000128	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PSMD7—kidney cancer	1.47e-06	0.000126	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.45e-06	0.000125	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—kidney cancer	1.43e-06	0.000123	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—BCHE—kidney cancer	1.39e-06	0.000119	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.37e-06	0.000118	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—kidney cancer	1.36e-06	0.000117	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.33e-06	0.000114	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—kidney cancer	1.32e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.32e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—kidney cancer	1.26e-06	0.000108	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.25e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—POMC—kidney cancer	1.2e-06	0.000103	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—POMC—kidney cancer	1.17e-06	0.0001	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—kidney cancer	1.14e-06	9.82e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.11e-06	9.5e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—kidney cancer	1.1e-06	9.45e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—kidney cancer	1.06e-06	9.09e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.05e-06	8.99e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.03e-06	8.81e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.02e-06	8.73e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.64e-07	8.28e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—kidney cancer	9.53e-07	8.19e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—POMC—kidney cancer	9.31e-07	8e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—kidney cancer	9.31e-07	7.99e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—kidney cancer	8.31e-07	7.14e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—kidney cancer	8.12e-07	6.97e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—kidney cancer	7.76e-07	6.66e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—kidney cancer	7.43e-07	6.38e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—POMC—kidney cancer	7.19e-07	6.17e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—kidney cancer	6.48e-07	5.56e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.87e-07	5.04e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—kidney cancer	5.73e-07	4.92e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—kidney cancer	5.73e-07	4.92e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—kidney cancer	5e-07	4.29e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—kidney cancer	4.57e-07	3.92e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.53e-07	3.03e-05	CbGpPWpGaD
